Related content

Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis

By Wakata N.   Saito T.   Tanaka S.   Hirano T.   Oka K.  

Clinical Neurology and Neurosurgery, Vol. 106, Iss. 1, 2003-12 ,pp. : 5-8

Elsevier

Access to resources Recommend Favorite

Myasthenia Gravis - cause of lithium-associated myasthenic syndrome?

By Sadick N.S.   Schanzer H.   Gilchrist J.M.  

Medical Update for Psychiatrists, Vol. 3, Iss. 4, 1998-07 ,pp. : 113-118

Elsevier

Access to resources Recommend Favorite

Electrophysiological studies in myasthenia gravis, myasthenic syndromes and botulism

By Schwartz M.S.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 45-45

Elsevier

Access to resources Recommend Favorite

Concurrence of non-myasthenic symptoms with myasthenia gravis

By Iseki K.   Mezaki T.   Kawamoto Y.   Tomimoto H.   Fukuyama H.   Shibasaki H.  

Neurological Sciences, Vol. 28, Iss. 2, 2007-04 ,pp. : 114-115

Springer Publishing Company

Access to resources Recommend Favorite

Stimulated single fiber electromyography in myasthenia gravis and Lambert-Eaton myasthenic syndrome

By Mano K.   Takegami T.   Watanabe H.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 170-170

Elsevier

Access to resources Recommend Favorite